1. Division of Translational Medicine and Human Genetics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;
2. National Cancer Institute, National Institutes of Health, Bethesda, MD;
3. Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;
4. Department of Laboratory Medicine, University of Washington, Seattle, WA;
5. Sparrow Cancer Center, Edward W. Sparrow Hospital Association, Lansing, MI;
6. Division of Haematology, North Shore Hospital, Auckland, New Zealand;
7. Division of Hematology, Department of Medicine, and Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN;
8. Department of Medicine, Emory University School of Medicine, Atlanta, GA;
9. Sir Y.K. Pao Centre for Cancer and Department of Medicine & Therapeutics, Prince of Wales Hospital, The Chinese University of Hong Kong, Hong Kong;
10. Department of Pathology, Children’s Hospital of Philadelphia, Philadelphia, PA;
11. Department of Hematology, Hôpital Saint Éloi University Hospital, Montpellier, France;
12. Department of Hematology, Takamatsu Red Cross Hospital, Takamatsu, Kagawa, Japan;
13. Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA;
14. School of Medicine, Stony Brook University, Stony Brook, NY;
15. Division of Pulmonary, Allergy, and Critical Care, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;
16. Department of Pathology, Weill Cornell Medical College, New York, NY;
17. Departamento de Oncologia Clínica e Experimental, Universidade Federal de São Paulo, São Paulo, Brazil;
18. Division of Hematology/Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA;
19. Department of Pediatrics, Texas Children’s Hospital, Houston, TX;
20. Department of Medicine, Brigham and Women’s Hospital, Boston, MA;
21. Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA;
22. Division of Hematology/Oncology, Mayo Clinic, Rochester, MN;
23. Department of Oncology, Oslo University Hospital–Norwegian Radium Hospital, Oslo, Norway;
24. Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada;
25. Center for Personalized Therapy and Clinical Trials Office, UC San Diego Moores Cancer Center, La Jolla, CA;
26. Department of Hematologic Oncology and Blood Disorders, Levine Cancer Institute, Carolinas HealthCare System, Charlotte, NC;
27. Departments of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, NY;
28. Department of Organic Fine Chemicals, The Institute of Scientific and Industrial Research, Osaka University, Osaka, Japan;
29. Myeloma Institute, University of Arkansas for Medical Sciences, Little Rock, AR; and
30. Department of Clinical Immunology, Hôpital Saint-Louis, Paris, France